PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 63.30
+0.50 (0.80%)
Mar 4, 2026, 11:10 AM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 9.02 billion as of March 3, 2026. Its market cap has decreased by -39.03% in one year.
Market Cap
9.02B
Enterprise Value
4.43B
Revenue
2.51B
Ranking
n/a
PE Ratio
5.40
Stock Price
63.30
Market Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 9.02B, an increase of 67.75%. That is a compound annual growth rate of 3.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 9.02B | -10.80% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiMed Biologics | 14.04B |
| Ever Supreme Bio Technology | 13.49B |
| Tanvex BioPharma | 12.96B |
| Medigen Vaccine Biologics | 11.67B |
| TCM Biotech International | 11.57B |
| Gongwin Biopharm Holdings | 9.86B |
| TaiGen Biopharmaceuticals Holdings | 8.79B |
| Acepodia | 7.89B |